SEC Comment Letter for PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981) (CNSY) — Jan 6, 2009

PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981)
Date: Jan. 6, 2009 · CIK: 0001095981 · Accession: 0000000000-09-000471

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-32501

Date

January 6, 2009

Author

Not clearly detected

Form

UPLOAD

Company

PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981)

Letter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 DIVISION OF CORPORATION FINANCE Mail Stop 3030 January 6, 2009 Mark E. Saad Chief Financial Officer Cytori Therapeutics, Inc. 3020 Callan Road San Diego, CA 92121 RE: Cytori Therapeutics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2007 Filed March 14, 2008 File No. 000-32501

Dear Mr. Saad: We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments. S i n c e r e l y , B r i a n C a s c i o A c c o u n t i n g B r a n c h C h i e f

Show Raw Text

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

       DIVISION OF
CORPORATION FINANCE

Mail Stop 3030

January 6, 2009

Mark E. Saad
Chief Financial Officer Cytori Therapeutics, Inc. 3020 Callan Road San Diego, CA  92121
 RE: Cytori Therapeutics, Inc.
  Form 10-K for the Fiscal Year Ended December 31, 2007
  Filed March 14, 2008
  File No. 000-32501

Dear Mr. Saad:   We have completed our review of your Form  10-K and related filings and do not, at this
time, have any further comments.            S i n c e r e l y ,            B r i a n  C a s c i o         A c c o u n t i n g  B r a n c h  C h i e f

SecProbe.io